Literature DB >> 16889434

Solubilization of single-wall carbon nanohorns using a PEG-doxorubicin conjugate.

Tatsuya Murakami1, Jing Fan, Masako Yudasaka, Sumio Iijima, Kiyotaka Shiba.   

Abstract

A procedure for dispersing oxidized single-wall carbon nanohorns (oxSWNHs) in aqueous solution using a polyethylene glycol-doxorubicin (PEG-DXR) conjugate is described. In this procedure, oxSWNHs were first incubated with PEG-DXR in dimethyl sulfoxide (DMSO) or N,N-dimethylformamide (DMF), two organic solvents with relatively high electric dipole moments, after which the solvent was gradually changed to an aqueous one via addition of water until the final concentration of DMSO or DMF reached 10%. The PEG-DXR-oxSWNH complex that was obtained was able to pass through dextran-based chromatographic media (Sephadex G25) equilibrated with water. By contrast, untreated oxSWNHs and DXR-treated or PEG-treated oxSWNHs were unable to penetrate the column, indicating that the PEG-DXR conjugate endowed oxSWNHs with dispersibility in aqueous solution. In gel filtration experiments, the presence of free DXR had an inhibitory effect on the penetrability of PEG-DXR-oxSWNH complexes, which is consistent with the idea that PEG-DXR interacts with the surfaces of oxSWNHs via its DXR moiety. Quantitative analyses showed that the complex contained more than 250 mg of PEG-DXR for each gram of oxSWNHs. The average diameter of the dispersed complex was estimated to be approximately 160 nm using dynamic light scattering analysis. These results suggest that our method has the potential to open the way for the use of oxSWNHs as a clinically practical drug carrier.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16889434     DOI: 10.1021/mp060027a

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  7 in total

1.  Carbon Nanotubes in Biology and Medicine: In vitro and in vivo Detection, Imaging and Drug Delivery.

Authors:  Zhuang Liu; Scott Tabakman; Kevin Welsher; Hongjie Dai
Journal:  Nano Res       Date:  2009-02-01       Impact factor: 8.897

2.  Density functional and molecular docking studies towards investigating the role of single-wall carbon nanotubes as nanocarrier for loading and delivery of pyrazinamide antitubercular drug onto pncA protein.

Authors:  Nabanita Saikia; Sanchaita Rajkhowa; Ramesh C Deka
Journal:  J Comput Aided Mol Des       Date:  2013-02-15       Impact factor: 3.686

3.  In vitro and in vivo studies of single-walled carbon nanohorns with encapsulated metallofullerenes and exohedrally functionalized quantum dots.

Authors:  Jianfei Zhang; Jiechao Ge; Michael D Shultz; Eunna Chung; Gurpreet Singh; Chunying Shu; Panos P Fatouros; Scott C Henderson; Frank D Corwin; David B Geohegan; Alex A Puretzky; Christopher M Rouleau; Karren More; Christopher Rylander; Marissa Nichole Rylander; Harry W Gibson; Harry C Dorn
Journal:  Nano Lett       Date:  2010-08-11       Impact factor: 11.189

4.  Absorption and scattering properties of carbon nanohorn-based nanofluids for direct sunlight absorbers.

Authors:  Luca Mercatelli; Elisa Sani; Giovanni Zaccanti; Fabrizio Martelli; Paola Di Ninni; Simona Barison; Cesare Pagura; Filippo Agresti; David Jafrancesco
Journal:  Nanoscale Res Lett       Date:  2011-04-04       Impact factor: 4.703

5.  The application of carbon nanotubes in target drug delivery systems for cancer therapies.

Authors:  Wuxu Zhang; Zhenzhong Zhang; Yingge Zhang
Journal:  Nanoscale Res Lett       Date:  2011-10-13       Impact factor: 4.703

6.  The interactions of single-wall carbon nanohorns with polar epithelium.

Authors:  Yujie Shi; Zujin Shi; Suxin Li; Yuan Zhang; Bing He; Dong Peng; Jie Tian; Ming Zhao; Xueqing Wang; Qiang Zhang
Journal:  Int J Nanomedicine       Date:  2017-06-01

7.  Immobilization of a carbon nanomaterial-based localized drug-release system using a bispecific material-binding peptide.

Authors:  Katsutoshi Kokubun; Sachiko Matsumura; Masako Yudasaka; Sumio Iijima; Kiyotaka Shiba
Journal:  Int J Nanomedicine       Date:  2018-03-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.